Phase 2 Blepharitis Clinical Trials

4 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–4 of 4 trials

Recruiting

Phase 2

A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.

Blepharitis

Aperta Biosciences, LLC100 enrolled2 locationsNCT06720896

Recruiting

Phase 2

Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis

Demodex Blepharitis

Glaukos Corporation250 enrolled1 locationNCT07400965

Completed

Phase 2

Study Evaluating a New Drug to Treat Participants with Eyelid Inflammation Related to a Parasite (Demodex)

Blepharitis due to Demodex infestationBlepharitis

Roberto González Salinas, MD60 enrolled1 locationACTRN12620000320954

Not Yet Recruiting

Phase 2

Can castor oil improve tear film and ocular surface quality?

Blepharitis

The University of Auckland60 enrolled1 locationACTRN12618000856213